Biopharma Solutions

About CardioDiagnostics Inc.

Cardio Diagnostics is a commercial-stage biotech company with a mission to transform cardiovascular care from reactive to proactive using its unique AI-powered epigenetic platform. The company has achieved key milestones by launching its first commercial tests, Epi+Gen CHD and PrecisionCHD, targeting the massive and underserved market for early coronary heart disease detection. Its strategy involves a multi-pronged commercial approach, engaging healthcare providers, employers, and biopharma partners to drive adoption and generate data-driven insights across the care continuum.

Therapeutic Areas